Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
About this item
Full title
Author / Creator
Ferrari, Silvia Martina , Bocci, Guido , Di Desidero, Teresa , Ruffilli, Ilaria , Elia, Giusy , Ragusa, Francesca , Fioravanti, Anna , Orlandi, Paola , Paparo, Sabrina Rosaria , Patrizio, Armando , Piaggi, Simona , La Motta, Concettina , Ulisse, Salvatore , Baldini, Enke , Materazzi, Gabriele , Miccoli, Paolo , Antonelli, Alessandro and Fallahi, Poupak
Publisher
Greece: Spandidos Publications
Journal title
Language
English
Formats
Publication information
Publisher
Greece: Spandidos Publications
Subjects
More information
Scope and Contents
Contents
The antitumor activity of vandetanib [a multiple signal transduction inhibitor including the RET tyrosine kinase, epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF) receptor (VEGFR), ERK and with antiangiogenic activity], in primary anaplastic thyroid cancer (ATC) cells, in the human cell line 8305C [undifferentiated...
Alternative Titles
Full title
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Authors, Artists and Contributors
Author / Creator
Bocci, Guido
Di Desidero, Teresa
Ruffilli, Ilaria
Elia, Giusy
Ragusa, Francesca
Fioravanti, Anna
Orlandi, Paola
Paparo, Sabrina Rosaria
Patrizio, Armando
Piaggi, Simona
La Motta, Concettina
Ulisse, Salvatore
Baldini, Enke
Materazzi, Gabriele
Miccoli, Paolo
Antonelli, Alessandro
Fallahi, Poupak
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2021676654
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2021676654
Other Identifiers
ISSN
1021-335X
E-ISSN
1791-2431
DOI
10.3892/or.2018.6305
